EUVIMEDEUVIMED entdecken
Crossref

Synthesis and biological evaluation of benzamide‐chalcone hybrids as potential c‐Met kinase and COX‐2 inhibitors

Heena Bhojwani, Khushboo Begwani, Vikrant Bhor, Parul Bedi, Nafisa Balasinor, Sanketa Raut, Urmila Joshi

Archiv der Pharmazie · 2023

DOI: 10.1002/ardp.202200405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2023. Verfasst von Heena Bhojwani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Principal K. M. Kundnani College of Pharmacy, Colaba, Cuffe Parade, Mumbai, India. Hauptthemen laut MEDLINE: Chalcones, Chalcone, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

c‐Met kinase and cyclooxygenase 2 (COX‐2) enzymes are two significant targets in tumor progression. Chalcone and benzamide moieties were combined using molecular hybridization to assess their potential as c‐Met kinase and COX‐2 inhibitors. 4‐Methylbenzamide and 4‐chlorobenzamide chalcone analogs were synthesized, characterized, and evaluated for antiproliferative activity on Michigan Cancer Foundation‐7 (MCF‐7), HT‐29, MDA‐MB‐231, COLO‐205, and A549 cell lines by sulforhodamine‐B stain (SRB) assay. Following the SRB assay, compounds were evaluated for their c‐Met kinase and COX‐2 inhibitory potential. All compounds inhibited COX‐2 with half‐maximal inhibitory concentration (IC 50 )

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChalconesChalconeAntineoplastic AgentsHumansMolecular StructureStructure-Activity RelationshipCyclooxygenase 2 InhibitorsCyclooxygenase 2Serum Albumin, BovineBenzamidesCell ProliferationDrug Screening Assays, AntitumorCell Line, TumorMolecular Docking Simulation

Stichwörter der Autor:innen

COX-2anticancer activityc-Met kinasechalconesmolecular docking

Substanzen

Cyclooxygenase 2 InhibitorsChalconesChalconeCyclooxygenase 2Serum Albumin, BovineBenzamidesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Principal K. M. Kundnani College of Pharmacy, Colaba, Cuffe Parade, Mumbai, India.
  • Department of Molecular Immunology and Microbiology, National Institute for Research in Reproductive and Child Health, Parel, Mumbai, India.
  • Department of Neuroendocrinology, National Institute for Research in Reproductive and Child Health, Parel, Mumbai, India.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Bhojwani, H., Begwani, K., Bhor, V., Bedi, P., Balasinor, N., Raut, S., & Joshi, U. (2023). Synthesis and biological evaluation of benzamide‐chalcone hybrids as potential c‐Met kinase and COX‐2 inhibitors. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202200405

Vancouver

Bhojwani H, Begwani K, Bhor V, Bedi P, Balasinor N, Raut S, et al. Synthesis and biological evaluation of benzamide‐chalcone hybrids as potential c‐Met kinase and COX‐2 inhibitors. Archiv der Pharmazie. 2023. doi:10.1002/ardp.202200405

BibTeX
@article{Bhojwani2023,
  author = {Bhojwani, Heena and Begwani, Khushboo and Bhor, Vikrant and Bedi, Parul and Balasinor, Nafisa and Raut, Sanketa and Joshi, Urmila},
  title = {Synthesis and biological evaluation of benzamide‐chalcone hybrids as potential c‐Met kinase and COX‐2 inhibitors},
  journal = {Archiv der Pharmazie},
  year = {2023},
  doi = {10.1002/ardp.202200405}
}
Kostenlos starten →